Avanos Medical, Inc. financial data

Symbol
AVNS on NYSE
Location
5405 Windward Parkway, Suite 100 South, Alpharetta, GA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 242 % +1.42%
Quick Ratio 89.4 % +12.7%
Debt-to-equity 34.9 % -6.2%
Return On Equity -50.4 % -8137%
Return On Assets -37.4 % -8274%
Operating Margin -68 % -2143%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46.4M shares +0.99%
Common Stock, Shares, Outstanding 46.3M shares +0.87%
Entity Public Float 907M USD -23.9%
Common Stock, Value, Issued 500K USD 0%
Weighted Average Number of Shares Outstanding, Basic 46.3M shares +0.87%
Weighted Average Number of Shares Outstanding, Diluted 46.3M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 693M USD +1.48%
Research and Development Expense 24.1M USD -8.02%
Operating Income (Loss) -471M USD -2174%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -477M USD -3509%
Income Tax Expense (Benefit) -15.9M USD -327%
Net Income (Loss) Attributable to Parent -463M USD -6116%
Earnings Per Share, Basic -10 USD/shares -6024%
Earnings Per Share, Diluted -10 USD/shares -6024%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 90.3M USD -2.06%
Inventory, Net 143M USD -12.9%
Assets, Current 356M USD -24.9%
Deferred Income Tax Assets, Net 25.3M USD +302%
Property, Plant and Equipment, Net 114M USD +3.25%
Operating Lease, Right-of-Use Asset 31.1M USD +5.78%
Intangible Assets, Net (Excluding Goodwill) 105M USD -53.4%
Goodwill 381M USD -52%
Other Assets, Noncurrent 25.7M USD +53.9%
Assets 1.04B USD -37.3%
Accounts Payable, Current 48.8M USD -5.06%
Accrued Liabilities, Current 66M USD -17%
Liabilities, Current 135M USD -35.4%
Deferred Income Tax Liabilities, Net 6.3M USD -73.1%
Operating Lease, Liability, Noncurrent 21.8M USD -24.3%
Other Liabilities, Noncurrent 4.3M USD -59%
Liabilities 263M USD -39.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -32M USD +14.7%
Retained Earnings (Accumulated Deficit) -777M USD -148%
Stockholders' Equity Attributable to Parent 776M USD -36.5%
Liabilities and Equity 1.04B USD -37.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 25.7M USD
Net Cash Provided by (Used in) Financing Activities -29.1M USD -4057%
Net Cash Provided by (Used in) Investing Activities -9.1M USD -355%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.7M USD +10.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 90.3M USD -2.06%
Deferred Tax Assets, Valuation Allowance 3.9M USD -9.3%
Deferred Tax Assets, Gross 59.2M USD +2.6%
Operating Lease, Liability 35.5M USD -13.6%
Depreciation 19.3M USD -3.98%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -458M USD -32593%
Lessee, Operating Lease, Liability, to be Paid 48.2M USD -9.4%
Property, Plant and Equipment, Gross 261M USD +8.71%
Operating Lease, Liability, Current 10.4M USD -27.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.4M USD -20.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.2M USD -17%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +22.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.9M USD -49.4%
Deferred Tax Assets, Operating Loss Carryforwards 8.4M USD -18.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.5M USD -43.5%
Additional Paid in Capital 1.69B USD +0.92%
Amortization of Intangible Assets 213M USD +767%
Depreciation, Depletion and Amortization 9.6M USD -15.8%
Deferred Tax Assets, Net of Valuation Allowance 55.3M USD +3.56%
Share-based Payment Arrangement, Expense 14.3M USD -6.54%
Interest Expense 14.6M USD +19.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%